Emcure Pharmaceuticals SA (pty) Ltd Pharmaceutical Import Profile — South Africa (DGFT 2022–2026)

Name: Emcure Pharmaceuticals SA (pty) Ltd Pharmaceutical Import Records from India — 2 Products, $6.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Emcure Pharmaceuticals SA (pty) Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $6.7M Trade | TransData Nexus

Emcure Pharmaceuticals SA (pty) Ltd

Pharmaceutical Importer · South Africa · Antiviral & HIV Medications Focus · $6.7M Total Trade · DGFT Verified

Emcure Pharmaceuticals SA (pty) Ltd is a pharmaceutical importer based in South Africa with a total trade value of $6.7M across 2 products in 1 therapeutic categories. Based on 133 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Emcure Pharmaceuticals SA (pty) Ltd sources from 1 verified Indian supplier, with Emcure Pharmaceuticals Limited accounting for 100.0% of imports.

Emcure Pharmaceuticals SA (pty) Ltd — Import Portfolio & Supplier Network

Emcure Pharmaceuticals SA (pty) Ltd import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Emcure Pharmaceuticals SA (pty) Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Emcure Pharmaceuticals Limited	$627.4K	13	100.0%

Emcure Pharmaceuticals SA (pty) Ltd sources from 1 verified Indian supplier across 8 distinct formulations. The sourcing is highly concentrated — Emcure Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Pharma prod finished prod lavem 50 300 300 MG tablet 90s wtc dolutegravir lamivudine tenofovir disoproxil	$250.0K	5
Pharma prod finished prod cagol 600 50 300 MG tablet 28s abacavir dolutegravir lamivudine tablets 600 50 300MG	$100.0K	2
Pharmaceutical products finished product lavem 50 300 300 MG tablet 90s wtc dolutegravir lamivudine tenofovir	$50.0K	1
Pharmaceutical products finished goods lavem 50 300 300 MG tablet 90s wtc dolutegravir lamivudine tenofovir	$50.0K	1
Pharmaceuticals products finished product generic name lavem 50 300 300 mgtablet 90s wtc dolutegravir	$50.0K	1
Pharma prod finished prod cagol 600 50 300 MG tablet 28sabacavir dolutegravir lamivudine tablets 600 50 300MG	$50.0K	1
Pharmaceuticals products finished product generic name nitrofurantoin 100mgcapsule 5x10 nitrofurantoin	$46.9K	1
Pharmaceuticals products finished product generic name nitrofurantoin 50mgcapsule 5x10t nitrofurantoin	$30.5K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dolutegravir	Antiviral & HIV Medications	$4.1M	82	0.1%	3
2	Tenofovir	Antiviral & HIV Medications	$2.5M	51	0.1%	10

Emcure Pharmaceuticals SA (pty) Ltd imports 2 pharmaceutical products across 1 categories into South Africa totaling $6.7M.

Emcure Pharmaceuticals SA (pty) Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Emcure Pharmaceuticals SA (Pty) Ltd is a pharmaceutical importer and distributor based in Johannesburg, South Africa. As a subsidiary of Emcure Pharmaceuticals Limited, an Indian multinational pharmaceutical company headquartered in Pune, India, Emcure Pharmaceuticals SA (Pty) Ltd plays a pivotal role in the South African pharmaceutical supply chain. The parent company, Emcure Pharmaceuticals Limited, is renowned for its extensive portfolio, including tablets, capsules, injectables, and biotherapeutics across various therapeutic areas such as gynaecology, cardiology, oncology, and HIV antivirals.

In South Africa, Emcure Pharmaceuticals SA (Pty) Ltd serves as a key importer and distributor, facilitating the availability of Emcure's pharmaceutical products within the country. The company's operations are integral to ensuring that a diverse range of medications reaches healthcare providers and patients across South Africa, thereby contributing to the nation's healthcare infrastructure.

2Distribution Network

Emcure Pharmaceuticals SA (Pty) Ltd operates from its office located at Arizona House, First Floor, South Wing, 1 Madison Avenue Aspen Lakes, Ext 13, Gauteng 2190, Johannesburg, South Africa. While specific details regarding warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in Johannesburg suggests a focus on efficient distribution within South Africa. Given Johannesburg's status as a major economic hub, Emcure Pharmaceuticals SA (Pty) Ltd is well-positioned to manage the importation and distribution of pharmaceutical products throughout the country.

3Industry Role

Emcure Pharmaceuticals SA (Pty) Ltd functions primarily as a pharmaceutical importer and distributor within South Africa's healthcare sector. By sourcing finished pharmaceutical formulations from its parent company, Emcure Pharmaceuticals Limited, the subsidiary ensures that a range of medications is accessible to South African healthcare providers and patients. This role is crucial in bridging the supply of pharmaceutical products from India to the South African market, thereby enhancing the availability of essential medicines.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Emcure Pharmaceuticals SA (pty) Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Emcure Pharmaceuticals SA (Pty) Ltd's sourcing strategy exhibits a high degree of concentration, with all its pharmaceutical imports originating from a single supplier: Emcure Pharmaceuticals Limited. This exclusive sourcing arrangement indicates a strategic partnership aimed at ensuring consistent product quality and supply chain reliability. The substantial import value of $6.7 million USD across 133 shipments underscores the significant volume of trade between the two entities. However, this single-source dependency also presents potential risks, such as supply chain disruptions due to unforeseen events affecting the sole supplier. The absence of alternative suppliers may limit Emcure Pharmaceuticals SA (Pty) Ltd's ability to mitigate such risks effectively.

2Supply Chain Resilience

The resilience of Emcure Pharmaceuticals SA (Pty) Ltd's supply chain is closely tied to the operational stability of Emcure Pharmaceuticals Limited. Given the exclusive sourcing relationship, any disruptions within the parent company's manufacturing or distribution processes could directly impact the subsidiary's ability to supply products in South Africa. The lack of backup suppliers and limited formulation diversity further heighten this vulnerability. Additionally, the reliance on a single shipping route for imports from India to South Africa exposes the supply chain to potential logistical challenges. Ensuring regulatory compliance of the key supplier is essential to maintain uninterrupted supply; however, the absence of alternative suppliers may complicate the process of obtaining necessary certifications and approvals.

Importing Pharmaceuticals into South Africa — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for South Africa

1Regulatory Authority & Framework

In South Africa, the South African Health Products Regulatory Authority (SAHPRA) is the primary body responsible for regulating the importation, registration, and distribution of medical products, including pharmaceuticals. SAHPRA operates under the Medicines and Related Substances Act 101 of 1965, as amended, which outlines the legal framework for the control of medicines and related substances in the country. This legislation mandates that all medicines imported into South Africa must be registered with SAHPRA, ensuring they meet the required standards of safety, efficacy, and quality. (sahpra.org.za)

2Import Licensing & GMP

To import pharmaceutical products into South Africa, companies must obtain an import license from SAHPRA. This license is contingent upon the supplier's adherence to Good Manufacturing Practices (GMP), which are internationally recognized standards ensuring the quality and safety of pharmaceutical products. SAHPRA requires that all pharmaceutical manufacturers and wholesalers comply with GMP guidelines, which are periodically updated to reflect best practices. Additionally, companies must be licensed and recorded as a manufacturing or wholesale pharmacy with the South African Pharmacy Council, and appoint a responsible pharmacist to oversee operations.

Emcure Pharmaceuticals SA (pty) Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Emcure Pharmaceuticals SA (Pty) Ltd's focus on importing antiviral and HIV medications, particularly Dolutegravir and Tenofovir, aligns with the significant demand for HIV treatment options in South Africa. The country's high HIV prevalence necessitates a steady supply of effective antiretroviral therapies. By concentrating on these therapeutic areas, Emcure Pharmaceuticals SA (Pty) Ltd addresses a critical public health need, ensuring that patients have access to essential medications that are vital for managing and treating HIV infections.

2Sourcing Profile

Emcure Pharmaceuticals SA (Pty) Ltd's sourcing strategy is centered on obtaining finished pharmaceutical formulations from its parent company, Emcure Pharmaceuticals Limited. This approach leverages the parent company's extensive research and development capabilities, ensuring access to a diverse range of high-quality products. The focus on finished formulations, rather than active pharmaceutical ingredients (APIs) or bulk drugs, indicates a strategic decision to streamline operations and maintain consistent product quality. India's robust pharmaceutical manufacturing sector, characterized by adherence to international standards, complements Emcure Pharmaceuticals SA (Pty) Ltd's procurement strategy, facilitating the importation of reliable and effective medications.

Market Positioning

Seller's Guide — How to Become a Supplier to Emcure Pharmaceuticals SA (pty) Ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, there exists a realistic opportunity to collaborate with Emcure Pharmaceuticals SA (Pty) Ltd by offering complementary products that align with the company's existing portfolio. Introducing alternative suppliers could help mitigate the risks associated with single-source dependency and provide Emcure Pharmaceuticals SA (Pty) Ltd with additional options to meet market demand. However, any new supplier would need to demonstrate compliance with SAHPRA's regulatory requirements, including GMP standards and product registration, to establish a successful partnership.

2Requirements & Qualifications

Indian exporters aiming to supply Emcure Pharmaceuticals SA (Pty) Ltd and the broader South African market must adhere to SAHPRA's regulatory framework. This includes obtaining an import license, ensuring compliance with GMP standards, and registering products with SAHPRA. Additionally, exporters must ensure that their products meet South Africa's labeling requirements and any serialization mandates. Establishing a partnership with Emcure Pharmaceuticals SA (Pty) Ltd would also necessitate alignment with the company's quality standards

Frequently Asked Questions — Emcure Pharmaceuticals SA (pty) Ltd

What products does Emcure Pharmaceuticals SA (pty) Ltd import from India?

Emcure Pharmaceuticals SA (pty) Ltd imports 2 pharmaceutical products across 1 categories. Top imports: Dolutegravir ($4.1M), Tenofovir ($2.5M).

Who supplies pharmaceuticals to Emcure Pharmaceuticals SA (pty) Ltd from India?

Emcure Pharmaceuticals SA (pty) Ltd sources from 1 verified Indian suppliers. The primary supplier is Emcure Pharmaceuticals Limited (100.0% of imports, $627.4K).

What is Emcure Pharmaceuticals SA (pty) Ltd's total pharmaceutical import value?

Emcure Pharmaceuticals SA (pty) Ltd's total pharmaceutical import value from India is $6.7M, based on 133 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Emcure Pharmaceuticals SA (pty) Ltd focus on?

Emcure Pharmaceuticals SA (pty) Ltd imports across 1 categories. The largest: Antiviral & HIV Medications (100.0%).

Get Full Emcure Pharmaceuticals SA (pty) Ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.